Surmodics Reports First Quarter Fiscal 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
SurModics (SRDX) PT Lowered to $69 at Needham & Company
January 31, 2019 8:26 AM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining a Buy rating.
Matson commented, "RDX beat consensus F1Q19 revenue and EPS estimates. Management raised the lower end of its FY19 revenue guidance and narrowed... More
SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus
January 30, 2019 4:31 PM ESTSurModics (NASDAQ: SRDX) reported Q1 EPS of $0.12, versus $0.10 reported last year. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.18 million.
Revenue of $22.2 million, an increase of 31% year-over-yearGAAP EPS of $0.09, non-GAAP EPS of $0.12Updating fiscal 2019... More